Shares of Thyrocare Technologies surged 11% in Friday’s trade after the company reported strong consolidated Q4FY26 earnings, driven by robust growth in profit, revenue, and operating margins. As of 9:27 AM, the shares were trading 11.36% higher at Rs 524.15.
The diagnostic services provider also announced a final dividend of ₹7 per equity share, further boosting investor sentiment.
Thyrocare Q4FY26 Results
Thyrocare reported a consolidated net profit of ₹47.1 crore in the January–March 2026 quarter, marking a sharp 117% rise compared to ₹21.7 crore reported in the corresponding quarter last year.
Revenue from operations increased 19.7% YoY to ₹224 crore against ₹187.2 crore in Q4FY25, reflecting healthy demand across its diagnostics and preventive healthcare segments.
The company’s EBITDA climbed 30.1% YoY to ₹75.1 crore from ₹57.7 crore in the year-ago quarter. EBITDA margin improved to 33.5% compared to 30.8% last year, indicating better operational efficiency and improved profitability.
Following the strong quarterly performance, Thyrocare shares rallied around 11% during the morning trading session as investors cheered the sharp profit growth, margin expansion, and dividend announcement.